Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking

Trial Profile

Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Varenicline (Primary)
  • Indications Schizoaffective disorder; Schizophrenia; Smoking withdrawal
  • Focus Therapeutic Use
  • Acronyms SCRP
  • Most Recent Events

    • 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jul 2008 Status changed from initiated to recruiting based on information from ClinicalTrials.gov.
    • 12 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top